Grayslake, IL, United States of America

Kenton L Longenecker

USPTO Granted Patents = 27 

 

 

Average Co-Inventor Count = 11.2

ph-index = 6

Forward Citations = 169(Granted Patents)


Company Filing History:


Years Active: 2007-2019

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):

Title: Innovations of Kenton L Longenecker

Introduction

Kenton L Longenecker, based in Grayslake, IL, has made significant contributions to the field of biopharmaceutical research, holding 27 patents to his name. His inventions focus on crucial aspects of immunology and oncology, showcasing his dedication to advancing medical science.

Latest Patents

Among his latest innovations are two notable patents. The first, titled "Tricyclic modulators of TNF signaling," provides a range of tricyclic heterocyclic compounds. These compounds include pharmaceutically acceptable salts and biologically active metabolites, which may prove beneficial in treating various immunological and oncological conditions. The second patent, "Prolactin receptor binding proteins and uses thereof," encompasses innovative PRLR binding proteins. This invention specifically involves chimeric, CDR grafted, and humanized antibodies with high affinity for the human prolactin receptor (hPRLR). These antibodies are designed to neutralize hPRLR activity and have applications in diagnosing and treating disorders related to detrimental hPRLR activity, including the development of antibody-drug conjugates.

Career Highlights

Kenton has had an impactful career working with leading pharmaceutical companies, including AbbVie Inc. and Abbott Laboratories Corporation. His work at these institutions has enabled him to engage in groundbreaking research and contribute to the development of novel therapeutic agents.

Collaborations

During his career, Kenton L Longenecker has collaborated with notable professionals in the industry, including Kent D Stewart and Rolf Wagner. These collaborations have fostered innovation and driven projects that push the boundaries of existing medical knowledge.

Conclusion

Kenton L Longenecker's achievements in securing numerous patents reflect his commitment to advancements in the field of biopharmaceuticals. His contributions have the potential to make a significant impact on the treatment of immunological and oncological conditions, showcasing the importance of innovation in the medical sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…